Sector |
|
Compare with Sector peers |
Industry |
|
Compare with Industry peers |
Website | http://www.indousagriseeds.com | |
Market Cap | 388.01 Cr. | |
Enterprise Value(EV) | 402.96 Cr. | 2023-09 |
Financial Indicators | ||
---|---|---|
Earnings per share (EPS) | 3.61 | Trailing Twelve Months Ending 2023-03 |
Price-Earning Ratio (PE) | 53.59 | Trailing Twelve Months Ending 2023-03 |
Industry PE | 70.99 | Trailing Twelve Months Ending 2023-03 |
Book Value / Share | 28.71 | Trailing Twelve Months Ending 2023-03 |
Price to Book Value | 6.74 | Calculated using Price: 193.50 |
Dividend Yield | 0.00 | Period Ending 2023-03 |
No. of Shares Subscribed | 2.01 Cr. | 20,052,000 Shares |
FaceValue | 10 | |
About Indo US Bio-Tech Ltd. | ||
The company is engaged in the business of breeding products, processing and marketing of high performing open-pollinated and hybrid agricultural seed varieties & (seed testing, soil & water testing). The company has its own laboratory for seed testing at Junagadh. In the initial stage, the company was engaged in producing different varieties of oilseeds and pulses seeds, later on, it also added vegetable, spices and cereals seeds to its basket. Its products are being marketed under various brands names like INDO-US 955, INDO-US 936, INDO-US 927 etc. It is 9001:2015 certified engaged in research plant, breeding products, processing and marketing of sales high performing open pollinated and hybrid agricultural seed varieties. Indo US Bio-Tech is a recognized seed importer from National Seeds Corporation Limited. |
1 Day |
|
+0.91% |
1 Week |
|
+3.20% |
1 Month |
|
-7.28% |
3 Month |
|
-28.64% |
6 Month |
|
+65.38% |
1 Year |
|
+203.86% |
2 Year |
|
+327.15% |
5 Year |
|
+900.52% |
10 Year |
|
9 years | 2015-03 | 2016-03 | 2017-03 | 2018-03 | 2019-03 | 2020-03 | 2021-03 | 2022-03 | 2023-03 | |
Return on Equity (%) | 19.83 | 11.69 | 11.74 | 34.36 | 22.21 | 16.74 | 26.87 | 17.34 | 15.51 | |
Return on Capital Employed (%) | 13.92 | 7.39 | 14.24 | 27.84 | 20.35 | 16.65 | 18.30 | 15.86 | 14.62 | |
Return on Assets (%) | 7.63 | 3.55 | 3.14 | 10.01 | 10.26 | 8.66 | 13.05 | 10.63 | 11.67 |
Particulars | 10 years | 2015-03 Rs. Cr. | 2016-03 Rs. Cr. | 2017-03 Rs. Cr. | 2018-03 Rs. Cr. | 2019-03 Rs. Cr. | 2020-03 Rs. Cr. | 2021-03 Rs. Cr. | 2022-03 Rs. Cr. | 2023-03 Rs. Cr. | 2023-09* Rs. Cr. |
Shh. Funds | 3 | 3 | 3 | 5 | 14 | 16 | 22 | 39 | 55 | 58 | |
Non Curr. Liab. | 0 | 0 | 0 | 1 | 1 | 2 | 4 | 4 | 2 | 4 | |
Curr. Liab. | 4 | 10 | 9 | 10 | 9 | 17 | 18 | 12 | 12 | 16 | |
Minority Int. | |||||||||||
Equity & Liab. | 7 | 13 | 12 | 17 | 24 | 35 | 43 | 55 | 69 | 78 | |
Non Curr. Assets | 1 | 1 | 1 | 2 | 3 | 3 | 5 | 8 | 9 | 11 | |
Curr. Assets | 6 | 12 | 11 | 15 | 21 | 32 | 38 | 47 | 60 | 67 | |
Misc. Exp. not W/O | 0 | 0 | 0 | ||||||||
Total Assets | 7 | 13 | 12 | 17 | 24 | 35 | 43 | 55 | 69 | 78 |
Particulars | 10 years | 2014-03 Rs. Cr. | 2015-03 Rs. Cr. | 2016-03 Rs. Cr. | 2017-03 Rs. Cr. | 2018-03 Rs. Cr. | 2019-03 Rs. Cr. | 2020-03 Rs. Cr. | 2021-03 Rs. Cr. | 2022-03 Rs. Cr. | 2023-03 Rs. Cr. |
Net Sales | 15 | 20 | 19 | 25 | 30 | 35 | 40 | 40 | 50 | 62 | |
Other Income | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |
Total Income | 15 | 20 | 19 | 25 | 30 | 36 | 40 | 40 | 50 | 62 | |
Total Expenditure | -14 | -19 | -19 | -23 | -27 | -32 | -36 | -35 | -43 | -52 | |
PBIDT | 0 | 1 | 1 | 1 | 3 | 3 | 4 | 6 | 7 | 9 | |
Interest | 0 | 0 | 0 | -1 | -1 | 0 | -1 | -1 | -1 | -1 | |
Depreciation | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -1 | |
Taxation | 0 | 0 | 0 | 0 | -1 | -1 | 0 | 1 | 0 | 0 | |
Exceptional Items | 0 | ||||||||||
PAT | 0 | 1 | 0 | 0 | 1 | 2 | 3 | 5 | 5 | 7 | |
Adjusted EPS | 0 | 0 | 0 | 0 | 1 | 1 | 2 | 4 | 3 | 4 |
Particulars | 10 years | 2014-03 Rs. Cr. | 2015-03 Rs. Cr. | 2016-03 Rs. Cr. | 2017-03 Rs. Cr. | 2018-03 Rs. Cr. | 2019-03 Rs. Cr. | 2020-03 Rs. Cr. | 2021-03 Rs. Cr. | 2022-03 Rs. Cr. | 2023-03 Rs. Cr. |
Cash Fr. Operatn. | 0 | 0 | -3 | 0 | -1 | -3 | -1 | 0 | 3 | 1 | |
Cash Fr. Inv. | 0 | 0 | 0 | 0 | 0 | -3 | -1 | -2 | -5 | -7 | |
Cash Fr. Finan. | 0 | 0 | 3 | 0 | 1 | 6 | 2 | 1 | 2 | 6 | |
Net Change | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||
Cash & Cash Eqvt | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Thu, 09 Nov 2023
Announcement under Regulation 30 (LODR)-Newspaper Publication Newspaper Advertisement relating to the Unaudited financial results for the quarter & half year ended on 20th September 2023. |
Wed, 08 Nov 2023
Results- Financial Results For Sep 30 2023 Unaudited Financial Results for the quarter and half year ended on 30-09-2023. |
Wed, 08 Nov 2023
Board Meeting Outcome for Outcome Of Board Meeting Held On Wednesday November 8 2023 Pursuant To Regulation 30 Of The SEBI (Listing Obligation And Disclosure Requirements) Regulations 2015. Dear Sir Pursuant to the Regulation 30 of the SEBI (Listing Obligation and Disclosures Requirements) Regulation 2015 we wish to inform you that the Board of Directors of the Company at their meeting held on Wednesday 8th November 2023 at the registered office of the Company situated at 309 Shanti Mall Satadhar Char Rasta Opp. Navrang Tower Sola Road Ahmedabad Gujarat 380061 have considered and approved the following items of business:1. The Board approved unaudited financial results of the company for the quarter/half year ended 30th September 2023 along with limited review reports obtained from the Auditor of the Company.The Board Meeting commenced at 05.30 P.M. and concluded at 06:00 P.M.You are requested to kindly take the same on record.Thanking you |
Fri, 01 Dec 2023 |
|
|
|
|
|